Target Price | $7.14 |
Price | $2.41 |
Potential |
196.27%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Prokidney 2026 .
The average Prokidney target price is $7.14.
This is
196.27%
register free of charge
$9.45
292.12%
register free of charge
$1.01
58.09%
register free of charge
|
|
A rating was issued by 13 analysts: 8 Analysts recommend Prokidney to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Prokidney stock has an average upside potential 2026 of
196.27%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 0.08 | 0.16 |
95.50% | ||
EBITDA Margin | -216,150.00% | -114,043.83% |
47.24% | ||
Net Margin | -76,487.50% | -105,416.07% |
37.82% |
8 Analysts have issued a sales forecast Prokidney 2025 . The average Prokidney sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Prokidney EBITDA forecast 2025. The average Prokidney EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2024 | -216,150.00% | |
---|---|---|
2025 |
-114,043.83%
47.24%
Unlock
|
8 Prokidney Analysts have issued a net profit forecast 2025. The average Prokidney net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.62 | -0.56 |
8.77% | 9.68% | |
P/E | negative | |
EV/Sales | 2,650.76 |
8 Analysts have issued a Prokidney forecast for earnings per share. The average Prokidney EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
Guggenheim |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Sep 30 2024 |
Guggenheim |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
B of A Securities |
Locked
➜
Locked
|
Locked | Sep 04 2024 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Jul 15 2025 |
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 14 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Jul 09 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Jun 30 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 30 2024 |
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 10 2024 |
Locked
B of A Securities:
Locked
➜
Locked
|
Sep 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.